IMPPAT Phytochemical information: 
Oleoyl

Oleoyl
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese AdultsA Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Oleoyl-Estrone (MP-101) in Male Obese Adults.NCT00449254
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.G Protein-coupled Receptor in the Intestine (GPR 119) Stimulated GLP-1 SecretionNCT01043445
Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)A Phase 2a Randomized, Double-Blind, Placebo Controlled, Parallel Group, Safety and Efficacy Study of Two 14 Day Cycles of Oral Doses of Oleoyl-Estrone (MP-101) in Obese Adult SubjectsNCT00449202
The effect of Oleoyl ethanolamide (OEA) supplementation in patients with acute ischemic brain strokeThe effect of Oleoyl ethanolamide (OEA) supplementation on blood hematological parameters, lipid profile, biomarkers of oxidative stress and inflammatory parameters in the blood of patients with acute ischemic brain strokeIRCT20130501013194N4